Vetoquinol - Asset Resilience Ratio

Latest as of June 2025: 1.45%

Vetoquinol (VETO) has an Asset Resilience Ratio of 1.45% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore Vetoquinol long-term investment allocation to see how much of total assets are deployed in long-term investments.

Liquid Assets

€10.53 Million
≈ $12.31 Million USD Cash + Short-term Investments

Total Assets

€725.82 Million
≈ $848.56 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Vetoquinol's Asset Resilience Ratio has changed over time. See VETO defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Vetoquinol's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Vetoquinol.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €10.53 Million 1.45%
Total Liquid Assets €10.53 Million 1.45%

Asset Resilience Insights

  • Limited Liquidity: Vetoquinol maintains only 1.45% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Vetoquinol Industry Peers by Asset Resilience Ratio

Compare Vetoquinol's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.92%
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
Drug Manufacturers - Specialty & Generic 0.35%
Hainan Haiyao Co Ltd
SHE:000566
Drug Manufacturers - Specialty & Generic 3.27%
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
Drug Manufacturers - Specialty & Generic 10.89%
Shanxi Zhendong Pharmaceutical
SHE:300158
Drug Manufacturers - Specialty & Generic 10.74%
Yabao Pharmaceutical Group Co Ltd
SHG:600351
Drug Manufacturers - Specialty & Generic 0.27%

Annual Asset Resilience Ratio for Vetoquinol (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Vetoquinol.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.80% €20.82 Million
≈ $24.34 Million
€744.13 Million
≈ $869.97 Million
+2.99pp
2023-12-31 -0.19% €-1.32 Million
≈ $-1.55 Million
€692.23 Million
≈ $809.29 Million
-4.53pp
2022-12-31 4.34% €28.28 Million
≈ $33.06 Million
€651.85 Million
≈ $762.08 Million
+1.88pp
2021-12-31 2.46% €15.34 Million
≈ $17.93 Million
€624.56 Million
≈ $730.18 Million
+2.46pp
2020-12-31 0.00% €1.00K
≈ $1.17K
€646.09 Million
≈ $755.35 Million
-3.62pp
2019-12-31 3.62% €18.51 Million
≈ $21.64 Million
€511.47 Million
≈ $597.96 Million
-9.09pp
2018-12-31 12.71% €59.17 Million
≈ $69.18 Million
€465.58 Million
≈ $544.32 Million
+3.94pp
2017-12-31 8.77% €38.95 Million
≈ $45.53 Million
€443.97 Million
≈ $519.05 Million
+0.64pp
2016-12-31 8.13% €35.71 Million
≈ $41.75 Million
€439.17 Million
≈ $513.44 Million
+8.21pp
2012-12-31 -0.07% €-261.00K
≈ $-305.14K
€356.44 Million
≈ $416.71 Million
-0.07pp
2006-12-31 0.00% €-3.00K
≈ $-3.51K
€210.62 Million
≈ $246.24 Million
+0.00pp
2005-12-31 0.00% €-4.00K
≈ $-4.68K
€199.72 Million
≈ $233.49 Million
--
pp = percentage points

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic
Market Cap
$972.53 Million
€831.86 Million EUR
Market Cap Rank
#9080 Global
#145 in France
Share Price
€70.50
Change (1 day)
-0.70%
52-Week Range
€67.20 - €91.00
All Time High
€149.34
About

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more